Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinical and laboratory characteristics of the subjects

From: Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study

  Gout Healthy P
  (n = 103) (n = 204)  
Age, years 51.0 (16) 51.0 (14) 0.944*
Body mass index, kg/m2 25.8 (4.6) 23.5 (3.1) <0.001*
Visceral fat area, cm2 115.6 ± 25.3 97.7 ± 20.2 <0.001
Visceral fat obesity, VFA ≥100 cm2 74 (71.8%) 84 (41.2%) <0.001
Waist circumference, cm 91.2 ± 9.7 82.3 ± 7.5 <0.001
Hip circumference, cm 99.2 ± 7.4 94.0 ± 4.5 <0.001
Total fat mass, kg 20.1 (10.3) 14.9 (5.4) <0.001*
Total fat percentage, % 25.6 ± 5.7 21.7 ± 4.4 <0.001
Systolic blood pressure, mmHg 125.0 ± 13.8 118.5 ± 12.1 <0.001
Diastolic blood pressure, mmHg 80.4 ± 11.1 75.7 ± 9.9 0.001
Uric acid, mg/dL 7.9 ± 1.9 6.4 ± 6.0 0.001
Total cholesterol, mg/dL 191.2 ± 37.0 192.0 ± 27.2 0.857
Triglyceride, mg/dL 155.0 (118) 82.0 (52.0) <0.001*
High-density lipoprotein, mg/dL 44.0 (15.0) 51.0 (15.0) <0.001*
Low-density lipoprotein, mg/dL 114.3 ± 32.5 119.1 ± 25.5 0.159
Glucose, mg/dL 96.4 (16.0) 89.0 (10.0) <0.001*
  1. *Non-parametric Mann-Whitney U-test was used.
  2. mean ± standard deviation or median (interquartile range).